Article Details

Inotrem's COVID-19 Phase IIa Clinical Trial Declared “National Priority Research” by the French ...

Retrieved on: 2020-12-24 06:56:15

Tags for this article:

Click the tags to see associated articles and topics

Inotrem's COVID-19 Phase IIa Clinical Trial Declared “National Priority Research” by the French .... View article details on hiswai:

Excerpt

Inotrem S.A., a biotechnology company specialized in the development of immunotherapies targeting the TREM-1 pathway, announces today that its ...

Article found on: www.manchestertimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up